These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39190813)

  • 1. Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
    Bosman S; Ayakaka I; Muhairwe J; Kamele M; van Heerden A; Madonsela T; Labhardt ND; Sommer G; Bremerich J; Zoller T; Murphy K; van Ginneken B; Keter AK; Jacobs BKM; Bresser M; Signorell A; Glass TR; Lynen L; Reither K
    Clin Infect Dis; 2024 Nov; 79(5):1293-1302. PubMed ID: 39190813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.
    Turner CT; Gupta RK; Tsaliki E; Roe JK; Mondal P; Nyawo GR; Palmer Z; Miller RF; Reeve BW; Theron G; Noursadeghi M
    Lancet Respir Med; 2020 Apr; 8(4):407-419. PubMed ID: 32178775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental radiological findings during clinical tuberculosis screening in Lesotho and South Africa: a case series.
    Glaser N; Bosman S; Madonsela T; van Heerden A; Mashaete K; Katende B; Ayakaka I; Murphy K; Signorell A; Lynen L; Bremerich J; Reither K
    J Med Case Rep; 2023 Aug; 17(1):365. PubMed ID: 37620921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.
    Reeve BWP; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    Lancet Glob Health; 2024 May; 12(5):e793-e803. PubMed ID: 38583458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa.
    Gupta-Wright A; Ha H; Abdulgadar S; Crowder R; Emmanuel J; Mukwatamundu J; Marcelo D; Phillips PPJ; Christopher DJ; Nhung NV; Theron G; Yu C; Nahid P; Cattamanchi A; Worodria W; Denkinger CM;
    Lancet Glob Health; 2024 Feb; 12(2):e226-e234. PubMed ID: 38245113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study.
    Reeve BW; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    medRxiv; 2023 Jun; ():. PubMed ID: 37333303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
    Calderwood CJ; Reeve BW; Mann T; Palmer Z; Nyawo G; Mishra H; Ndlangalavu G; Abubakar I; Noursadeghi M; Theron G; Gupta RK
    J Infect; 2023 Jan; 86(1):24-32. PubMed ID: 36375640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms.
    Qin ZZ; Ahmed S; Sarker MS; Paul K; Adel ASS; Naheyan T; Barrett R; Banu S; Creswell J
    Lancet Digit Health; 2021 Sep; 3(9):e543-e554. PubMed ID: 34446265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of CAD4TB (Computer-Aided Detection for Tuberculosis) on paediatric chest radiographs.
    Edem VF; Nkereuwem E; Agbla SC; Owusu SA; Sillah AK; Saidy B; Jallow MB; Forson AG; Egere U; Kampmann B; Togun T
    Eur Respir J; 2024 Nov; 64(5):. PubMed ID: 39227074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda.
    Cox SR; Erisa KC; Kitonsa PJ; Nalutaaya A; Nantale M; Kayondo F; Mukiibi J; Mukiibi M; Nakasolya O; Dowdy DW; Katamba A; Kendall EA
    Ann Am Thorac Soc; 2024 Jun; 21(6):875-883. PubMed ID: 38259069
    [No Abstract]   [Full Text] [Related]  

  • 12. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.
    Kay AW; Ness T; Verkuijl SE; Viney K; Brands A; Masini T; González Fernández L; Eisenhut M; Detjen AK; Mandalakas AM; Steingart KR; Takwoingi Y
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013359. PubMed ID: 36065889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa.
    Ruperez M; Shanaube K; Mureithi L; Wapamesa C; Burnett MJ; Kosloff B; de Haas P; Hayes R; Fidler S; Gachie T; Schaap A; Floyd S; Klinkenberg E; Ayles H;
    Lancet Glob Health; 2023 May; 11(5):e704-e714. PubMed ID: 37061309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
    Dorman SE; Schumacher SG; Alland D; Nabeta P; Armstrong DT; King B; Hall SL; Chakravorty S; Cirillo DM; Tukvadze N; Bablishvili N; Stevens W; Scott L; Rodrigues C; Kazi MI; Joloba M; Nakiyingi L; Nicol MP; Ghebrekristos Y; Anyango I; Murithi W; Dietze R; Lyrio Peres R; Skrahina A; Auchynka V; Chopra KK; Hanif M; Liu X; Yuan X; Boehme CC; Ellner JJ; Denkinger CM;
    Lancet Infect Dis; 2018 Jan; 18(1):76-84. PubMed ID: 29198911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.
    Mishra H; Reeve BWP; Palmer Z; Caldwell J; Dolby T; Naidoo CC; Jackson JG; Schumacher SG; Denkinger CM; Diacon AH; van Helden PD; Marx FM; Warren RM; Theron G
    Lancet Respir Med; 2020 Apr; 8(4):368-382. PubMed ID: 32066534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.